Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a stressful drive reveal the secrets of insomnia?

NCT ID NCT02591303

Knowledge-focused Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how stress and insomnia are connected. Researchers used driving simulations with stressful events to measure emotional reactions and sleep patterns in 15 women with and without insomnia. The goal is to understand how stress affects sleep and vice versa, which could help prevent short-term sleep problems from becoming chronic insomnia.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help explain how short-term sleep problems turn into chronic insomnia, leading to better prevention and personalized treatments.
What could go wrong
This is a very small, early-stage study with only 15 women, so results may not apply to everyone. It is designed to gather knowledge, not test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

15 people

The number who actually took part.

Started

Nov 2015

Finished

Sep 2016

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 50 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Insomnia group: patients with insomnia (DSM-V criteria): sleep complaints, of more than 3 nights a week, more than 3 months, affected daytime functioning * Control group: no self-reported sleep problems * 20-50 years old * Female * Having given written informed consent to participate in the research project * Driving license Exclusion Criteria: * Night and shift-workers, * Psychiatric disorder: clinical mood disorder, anxiety disorder, psychosis, bipolar disorder, * For insomnia group: all sleep disorders other than persistent insomnia, * For control group: all sleep disorders * Progressive neurological diseases that include restless legs syndrome, * Cardiovascular disease other than treated hypertension, * Unstable respiratory or endocrinological diseases, * Reporting symptoms of menopause and/or taking hormone replacement therapy for menopause symptoms, * Drug addiction, alcohol addiction during the previous 6 months (smoking is allowed), * Having undertaken trans-meridian travel (± 3H) in the previous 1 month, * Pregnant or lactating women. * Chronic pain. * Having simulator-sickness during the first practice session * Hypnotic and psychotropic medication taking or stopped less than 5 half-life periods of molecules before screening V0. * A change in skin conductance of less than 0.05 microSiemens after an auditory stimulus. * Left-handedness * Patient participating to any other interventional study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Insomnia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

insomnia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Insomnia Stress

Contacts and locations

Locations

  • CHU de Bordeaux

    Bordeaux, 33000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.